|
PFAS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.308200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.321200E-01 |
| Normal-vs-Stage2 |
9.995000E-01 |
| Normal-vs-Stage3 |
1.838480E-02 |
| Normal-vs-Stage4 |
6.312200E-02 |
| Stage1-vs-Stage2 |
2.409400E-01 |
| Stage1-vs-Stage3 |
1.629750E-01 |
| Stage1-vs-Stage4 |
4.627000E-01 |
| Stage2-vs-Stage3 |
4.421800E-02 |
| Stage2-vs-Stage4 |
1.360230E-01 |
| Stage3-vs-Stage4 |
7.683600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.357600E-02 |
| Normal-vs-AfricanAmerican |
8.954000E-01 |
| Normal-vs-Asian |
9.397000E-01 |
| Caucasian-vs-AfricanAmerican |
2.504400E-01 |
| Caucasian-vs-Asian |
9.964300E-02 |
| AfricanAmerican-vs-Asian |
9.485400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.171220E-01 |
| Normal-vs-Female |
8.786000E-02 |
| Male-vs-Female |
9.932000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.828800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.343700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.789200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.060970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.739600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.108000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.052800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.071400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.790000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.864800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.393670E-02 |
| Classical-VS-Follicular |
1.947170E-01 |
| Classical-VS-Other |
2.481000E-01 |
| Classical-VS-Normal |
3.539600E-01 |
| Tall-VS-Follicular |
1.821400E-01 |
| Tall-VS-Other |
9.063200E-01 |
| Tall-VS-Normal |
2.704100E-03 |
| Follicular-VS-Other |
6.354800E-01 |
| Follicular-VS-Normal |
7.550300E-02 |
| Other-VS-Normal |
1.071230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.310240E-01 |
| Normal-vs-N1 |
2.788300E-02 |
| N0-vs-N1 |
2.559200E-01 |
|
|
